Skip to main content

Day: July 8, 2022

AgileThought and ExperienceIT Join Forces to Accelerate Digital Transformation for Clients Through Integrated Delivery Squads

Agile Squad AgileThought and EIT’s Integrated Delivery Squads offer world-class expertise in high impact technology domainsIRVING, Texas, July 08, 2022 (GLOBE NEWSWIRE) — AgileThought, Inc. (“AgileThought” or the “Company”) (Nasdaq: AGIL), a global provider of digital transformation services, custom software development, and next-generation technologies, and ExperienceIT, LLC (“ExperienceIT” or “EIT”), a digital transformation services firm based in Bloomington, Minnesota, announce a strategic partnership to help enterprises discover, design, and deliver on their digital strategic initiatives, at speed through the deployment of Integrated Delivery Squads. This new partnership enables clients to benefit from the combined strengths of the two firms to help them move faster to reach their digital transformation goals....

Continue reading

Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022

BOSTON, July 08, 2022 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients’ lives, announced today that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, is scheduled to participate in a fireside chat at the William Blair Biotech Focus Conference 2022, which will be available to view on-demand beginning Monday, July 11, 2022. Management will be available for in-person meetings at the conference on Tuesday, July 12, 2022. A webcast of the fireside chat will be available under the Investors and Media section of Aileron’s website at https://investors.aileronrx.com. A replay of the webcast will be archived on Aileron’s website for 30 days following the event. About Aileron TherapeuticsAileron...

Continue reading

All Court Interactive Enlisted to Help Santa as Grom and Curiosity Ink Media Prepare Santa.com for Christmas 2022!

Dedicated Team of Experts in Consumer Marketing, SEO and ECommerce Fortify Holiday Site Designed to Delight Every Member of the Family BOCA RATON, Fla., July 08, 2022 (GLOBE NEWSWIRE) — Grom Social Enterprises, Inc. (NASDAQ: GROM) (www.gromsocial.com) and its Hollywood-based original content division, Curiosity Ink Media, today announced that it has secured the expert services of All Court Interactive LLC to bolster consumer awareness, spur visitors, line the site’s shelves with gifts for whole family, and oversee retail affiliate relations for Santa.com, the digital holiday entertainment hub set to return this fall. This year, the site features a bold new look featuring a robust marketplace where consumers can fulfill all of their holiday needs. The selection of All Court was announced today by Darren Marks, Chairman & CEO,...

Continue reading

Aemetis Acquires 24 Acre Site in Riverbank, California for Carbon Capture and Sequestration Injection Well

Part of the 125-acre Riverbank Industrial Complex, the site is planned for the annual permanent sequestration of 1 million metric tonnes of carbon dioxide from industrial and agricultural sources CUPERTINO, Calif., July 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on below zero carbon intensity products, today announced the purchase of 24 acres, known as “Parcel B” on the Riverbank Industrial Complex site, to develop a Carbon Capture and Sequestration (CCS) injection well.  The company plans to construct a characterization well to obtain required data and final injection well design information that will be used for the EPA Class VI CO2 injection well permit application for the sequestration of approximately one million metric tonnes per...

Continue reading

ProMIS Neurosciences to Commence Trading on Nasdaq Under the Symbol “PMN”

TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 08, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, today announced that it has received final approval from The Nasdaq Capital Market LLC (“Nasdaq”) to list its common shares (the “Common Shares”) on Nasdaq. The Company’s Common Shares will begin trading on Friday, July 8th, 2022, under the symbol “PMN”. The Company’s Common Shares will continue to trade on the Toronto Stock Exchange (TSX) under the same symbol “PMN” (its current symbol). Concurrent with the listing of ProMIS’ Common Shares on Nasdaq, the Common Shares...

Continue reading

Is it a cocktail? Is it a popsicle? No, it’s a Poptail, brought to you by Goodfood

Goodfood Poptails Goodfood launches its PoptailsGoodfood Poptails Goodfood launches its PoptailsTORONTO, July 08, 2022 (GLOBE NEWSWIRE) —  Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD) a leading meal kit and online grocery company is launching a free summer treat. If you’re looking for the hottest (err, coolest) snack of the summer, look no further than Poptails; a flavour innovation that combines the season’s best boozy cocktails with the beloved taste of popsicles. While there’s lots of pops out there to choose from (we’re looking at you, ketchup popsicles) Poptails promise to cool you down…with a kick. There’s just no competition. Get your hands on yours all summer long at Goodfood Pop-ups (pun definitely intended) across the city. “As Canadians get outside and enjoy the summer months, Goodfood wanted to help...

Continue reading

Annexon Announces $130 Million Private Placement Financing

BRISBANE, Calif., July 08, 2022 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that it has entered into a securities purchase agreement for a private placement that is expected to result in gross proceeds of approximately $130 million, before deducting placement agent fees and other expenses. The private placement was led by Redmile Group, LLC, with participation by Adage Capital Partners LP, Bain Capital Life Sciences, Driehaus Capital Management, Fairmount, Satter Medical Technology Partners and Venrock Healthcare Capital Partners. In the private placement, Annexon is selling 9,013,834 shares of common stock, pre-funded...

Continue reading

Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program

Company previously announced positive top-line results from both ReOpen1 and ReOpen2, the landmark trials evaluating XHANCE as a treatment for chronic sinusitis Multiple secondary endpoints from ReOpen2 indicate patients treated with XHANCE experienced improvement in symptoms and quality of life when compared to patients treated with placebo In pooled data from ReOpen1 and ReOpen2, XHANCE demonstrated a benefit relative to placebo on CT scans in patients with chronic sinusitis without nasal polyps YARDLEY, Pa., July 08, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced additional results from the ReOpen trial program evaluating XHANCE for treatment of patients with chronic sinusitis. XHANCE® (fluticasone propionate)...

Continue reading

First Commonwealth to Host Second Quarter 2022 Earnings Conference Call on Wednesday, July 27, 2022

INDIANA, Pa., July 08, 2022 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) announced today that it will host a conference call on Wednesday, July 27, 2022 at 2:00 p.m. Eastern Time to discuss financial results for the quarter ended June 30, 2022. The call will be hosted by T. Michael Price, President and Chief Executive Officer. He will be joined by James R. Reske, Executive Vice President and Chief Financial Officer, Jane Grebenc, Executive Vice President and Chief Revenue Officer and Brian G. Karrip, Executive Vice President and Chief Credit Officer. First Commonwealth will issue a press release reporting its Second Quarter 2022 financial results after the market closes on Tuesday, July 26, 2022. Conference Call InformationWhat: First Commonwealth Financial Corporation     Second Quarter 2022...

Continue reading

Atlas to Participate in the CJS Securities 22nd Annual New Ideas Summer Conference

AUSTIN, Texas, July 08, 2022 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading Infrastructure and Environmental services provider, announced that L. Joe Boyer, Chief Executive Officer, and Jonathan Parnell, Chief Strategy Officer will participate in the CJS Securities 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022. About Atlas Technical ConsultantsHeadquartered in Austin, Texas, Atlas is a leading provider of Infrastructure and Environmental Solutions. We partner with our clients to improve performance and extend the lifecycle of built and natural infrastructure assets stressed by climate, health, and economic impacts. With 3,500+ employees nationwide, Atlas brings deep technical expertise to public- and private-sector clients, integrating services across...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.